WCG Clinical

MAY 15, 2023

By harnessing patient insights on clinical research technology, data accuracy can be improved, the clinical trial process can be streamlined, and the burden on participants and sites can be reduced. Additionally, on the back end, the database didn’t allow for proper analysis to satisfy regulators.

Clinical Research 52

Clinical Research Development Trials Research 52

Pharma Marketing Network

APRIL 30, 2021

Clinical trials may be one of the very last bastions of a non-customer-focused approach within the pharmaceutical industry. Across the board, from rheumatology to neurology, outcomes that matter most to patients, have traditionally not been captured in clinical trials. How do we increase the diversity of clinical trials?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

The Pharma Data

AUGUST 1, 2021

The adverse reactions that occurred more frequently in patients who received Saphnelo in the three clinical trials included nasopharyngitis, upper respiratory tract infection, bronchitis, infusion-related reactions, herpes zoster and cough. 12,13,14,15.

Trials 52

Trials Clinical Development Antibody Dermatology 52

Delveinsight

AUGUST 25, 2021

They are governed by a number of rules and regulations that govern drug patenting, testing, safety, efficacy, and marketing. . The Innovative Medicines Division focuses on Oncology, Immunology, Hepatology, Dermatology, Ophthalmology, Neuroscience, Cardiovascular, Renal and Metabolism, and Respiratory. trillion in 2021.

Vaccination 98

Vaccination Vaccine Sales Drugs 98

The Pharma Data

JANUARY 26, 2021

Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. As part of a global consortium, Appili is sponsoring late-stage clinical trials evaluating the antiviral Avigan® (favipiravir) for the worldwide treatment and prevention of COVID-19.

Life Science 40

Life Science Production Marketing Dermatology 40

The Pharma Data

JANUARY 13, 2021

Fast Track designation is well-timed, as we anticipate starting our Phase 2 clinical trial in hospitalized COVID-19 patients this month, and should help bring Brilacidin to patients faster in these dire times.”. Brilacidin, a versatile compound with broad therapeutic potential, is in a new chemical class called defensin-mimetics.

Clinical Trials 52

Clinical Trials Clinical Trials Trials In-Vitro 52

The Pharma Data

DECEMBER 15, 2020

We invest in differentiated and groundbreaking medical dermatology products to bring our innovative solutions to patients in need. Our Noble Purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”.

FDA Approval 52

FDA Approval Development Production Marketing 52

Drug Discovery World

APRIL 16, 2023

Adjuvant treatment with atezolizumab and bevacizumab Adjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) increased recurrence-free survival of patients with hepatocellular carcinoma (HCC) following surgical resection or ablation, according to the results from the Phase III IMbrave050 clinical trial.

Clinical Trials 52

Clinical Trials Clinical Trials Research Vaccination 52

pharmaphorum

JUNE 8, 2021

It is also due to start a phase 3 trial in atopic dermatitis later this year. The investment deal covers net sales of tapinarof in all dermatological indications in the US, and the cash injection will fund both milestone payments to GSK as well as cover launch costs. billion product. .

Sales 52

Sales Dermatology Licensing Licensing 52

The Pharma Data

JUNE 18, 2021

1 Significantly more patients receiving risankizumab 360 mg achieved clinical remission (CDAI; U.S. analysis plan), with 52 percent on risankizumab 360 mg achieving clinical remission versus 41 percent in the induction-only control group (p<0.01). 24th World Congress of Dermatology. vice chairman and president, AbbVie.

Trials 40

Trials Development Clinical Trials Clinical Trials 40

XTalks

AUGUST 2, 2023

In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. The TPO receptor agonist regulates blood platelet production by binding to and activating TPO receptors on megakaryocyte cells and inducing signalling cascades that increase platelet production.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

FEBRUARY 22, 2021

With a robust clinical trial program, AbbVie is committed to cutting-edge research to drive exciting developments in inflammatory bowel diseases (IBD), like ulcerative colitis and Crohn’s disease. European Academy of Dermatology and Venerology Congress. About AbbVie in Gastroenterology. Pipeline – Our Science | AbbVie.

Medicine 52

Medicine Development Drugs Trials 52

pharmaphorum

JANUARY 5, 2021

An IQVIA survey to Neurology, Cardiology, Rheumatology, Dermatology and Ophthalmologists in June 2020 across the lead five European countries showed an average of 30% of patients either “no shows” or still waiting for treatment that was delayed.

Sales 105

Sales Marketing Production Vaccination 105

pharmaphorum

JULY 9, 2021

The company has also expanded the platform into similar inflammatory conditions in rheumatology, dermatology and oncology. Regulation barriers. Parkes says that most of the app’s functions were built based on patient insights. “We

Doctors 69

Doctors Doctor Marketing Development 69

The Pharma Data

APRIL 26, 2021

COVID-19 negatively impacted demand, particularly: dermatology, ophthalmology, the breast cancer portfolio, Sandoz Retail and Anti-Infectives. The canakinumab development program continues, with two Ph3 non-small cell lung cancer clinical trials ongoing in first-line and adjuvant setting. Adakveo sales reached USD 37 million.

Sales 40

Sales Medicine Production Manufacturing 40